Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › EGFR and c-Met fibronectin type III domain binding molecules

EGFR and c-Met fibronectin type III domain binding molecules

US Patent 10954284 · Granted Mar 23, 2021

Estimated economic value: $120,756,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EPCAM binding fibronectin type III domains2025
Proteins comprising CD3 antigen binding domains and uses thereof2025
Combination therapies with bispecific anti-EGFR/c-met antibodies and third gener2025
Serum albumin-binding fibronectin type III domains and uses thereof2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025